anti tnf α d2d4 (Cell Signaling Technology Inc)
Structured Review
Anti Tnf α D2d4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d2d4/pm41893475-97-30-39
Average 86 stars, based on 1 article reviews
Images
Related Articles
Western Blot:Article Title: Effects of Fipronil Exposure on Glucose Metabolism Disorder via the Gut Microbiota and Inflammation. Article Snippet: .. Primary antibodies used for Western blotting included: anti-p-IR (Tyr1150/1151) (3024S), anti-IR (3025S), anti-p-AKT (Ser473) (9271S), anti-AKT (9272S), anti-p-GSK-3β (Ser9) (9336S), anti-GSK-3β (9315S) anti-tubulin (3873S), anti-IL-6 (D5W4V) (12912S), antiIL-1β (3A6) (12242S), Article Title: Effects of Fipronil Exposure on Glucose Metabolism Disorder via the Gut Microbiota and Inflammation Article Snippet: .. Primary antibodies used for Western blotting included: anti-p-IR (Tyr1150/1151) (3024S), anti-IR (3025S), anti-p-AKT (Ser473) (9271S), anti-AKT (9272S), anti-p-GSK-3β (Ser9) (9336S), anti-GSK-3β (9315S) anti-tubulin (3873S), anti-IL-6 (D5W4V) (12912S), anti-IL-1β (3A6) (12242S), Cell-Signaling:Article Title: Effects of Fipronil Exposure on Glucose Metabolism Disorder via the Gut Microbiota and Inflammation. Article Snippet: .. Primary antibodies used for Western blotting included: anti-p-IR (Tyr1150/1151) (3024S), anti-IR (3025S), anti-p-AKT (Ser473) (9271S), anti-AKT (9272S), anti-p-GSK-3β (Ser9) (9336S), anti-GSK-3β (9315S) anti-tubulin (3873S), anti-IL-6 (D5W4V) (12912S), antiIL-1β (3A6) (12242S), Article Title: Effects of Fipronil Exposure on Glucose Metabolism Disorder via the Gut Microbiota and Inflammation Article Snippet: .. Primary antibodies used for Western blotting included: anti-p-IR (Tyr1150/1151) (3024S), anti-IR (3025S), anti-p-AKT (Ser473) (9271S), anti-AKT (9272S), anti-p-GSK-3β (Ser9) (9336S), anti-GSK-3β (9315S) anti-tubulin (3873S), anti-IL-6 (D5W4V) (12912S), anti-IL-1β (3A6) (12242S), Article Title: Porcine decellularized splenic matrix hydrogel-based vesicle sustained-release System: A dual-regulatory biomaterial for accelerated wound healing via angiogenesis and immune remodeling Article Snippet: .. The antibodies used were as follows: Anti-CD31 antibody (FAB3628G, R&D Systems, USA; diluted 1:100), Anti-alpha-smooth muscle actin (α-SMA) antibody (ab7817, Abcam, UK; diluted 1:100), Anti-EMCN antibody (14-5851-82, Invitrogen, USA; diluted 1:200), Anti-F4/80 antibody (ab16911, Abcam, UK; diluted 1:200), Anti-iNOS antibody (ab178945, Abcam, UK; diluted 1:200), Anti-IL-6 antibody (12912s, Cell Signaling Technology, USA; diluted 1:200), Anti- Arginase 1(Arg1) antibody (93668s, Cell Signaling Technology, USA; diluted 1:200), Anti-CD4 antibody (11948s, Cell Signaling Technology, USA; diluted 1:200), Blocking Assay:Article Title: S-methylmethionine ameliorates renal injury in diabetic mice by modulating macrophage inflammaging via ERK/NF-κb signaling pathway. Article Snippet: Diabetic kidney disease (DKD) is a major microvascular complication of diabetes, yet current therapeutic strategies remain insufficient to halt its progression.. Emerging evidence suggests that macrophage-mediated inflammaging is a key pathogenic mechanism underlying diabetic renal injury, but effective targeted interventions are still limited.. In this study, we identify S-Methylmethionine (SMM) as a candidate therapeutic compound capable of modulating macrophage inflammaging, and systematically evaluate its protective potential. Incubation:Article Title: S-methylmethionine ameliorates renal injury in diabetic mice by modulating macrophage inflammaging via ERK/NF-κb signaling pathway. Article Snippet: Diabetic kidney disease (DKD) is a major microvascular complication of diabetes, yet current therapeutic strategies remain insufficient to halt its progression.. Emerging evidence suggests that macrophage-mediated inflammaging is a key pathogenic mechanism underlying diabetic renal injury, but effective targeted interventions are still limited.. In this study, we identify S-Methylmethionine (SMM) as a candidate therapeutic compound capable of modulating macrophage inflammaging, and systematically evaluate its protective potential. |


